Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0000950170-24-118982

Chief Financial Officer sold 9,102 shares at an average $6.03 ($54,905)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Catinazzo Thomas · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-10-28 Sale : show line 1 in the form 10b5-1 −1,697 $6.06 $10,284 311,496 D
2024-10-28 Sale : show line 2 in the form 10b5-1 −5,105 $6.06 $30,936 306,391 D
2024-10-29 Sale : show line 3 in the form 10b5-1 −2,300 $5.95 $13,685 304,091 D
Open-market sales · 9,102 sh · avg $6.03 · $54,905
Loading xslF345X05/ownership.xml…